California Prop 38 Immunotherapy Research Bond Leads in Early Counts, Promising a 20% Patient Discount on Future Treatments
California's Proposition 38 was leading as ballots were counted, but the result remained uncertified. The bond would fund research into cancer, heart disease and Alzheimer's at significant taxpayer cost.
Medical Daily ·